Treatment of Bacterial Meningitis in Infants Younger Than 1 Month

Bacterial meningitis in the neonatal period — infants under one month of age — represents a distinct and high-acuity clinical scenario that requires a tailored first-line antibiotic approach.

Clinical scenario: Infants younger than 1 month with bacterial meningitis. This age group has unique pathogen exposure risks and pharmacological considerations that set the treatment approach apart from older patients.

Treatment approach (partial)

Intravenous antibiotic therapy is indicated, with a combination regimen selected to address the pathogens predominant in this age group. The full protocol specifies the agents involved and the recommended alternative — see below for the complete regimen.

Treatment goal

Clinical improvement after 48 hours of appropriate treatment; lack of improvement at that point should prompt further evaluation.

Instant Access to Structured Evidence-Based Regimens

References

Infants younger than 1 month
Ampicillin plus cefotaxime (Claforan)
Alternative: ampicillin plus gentamicin
Intravenous antibiotics should be used to complete the full treatment course, but outpatient management can be considered in persons who are clinically improving after at least six days of therapy with reliable outpatient arrangements (i.e., intravenous access, home health care, reliable follow-up, and a safe home environment).
Repeat LP is generally not needed but should be considered to evaluate CSF parameters in persons who are not clinically improving after 48 hours of appropriate treatment.

View source ↗